MH

MindWalk Holdings Corp.

HYFT·NASDAQ

$1.82

+6.1%
HealthcareBiotechnology

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

At a Glance

Live Snapshot
Market Cap$84.87M
EPS-0.9100
P/E Ratio-2.00
Earnings Date03/26/2026

hyft

Research Development Expenses

Last Annual Value

4.94M

3-Year CAGR

-14%

5-Year CAGR

62%

10-Year CAGR

23%

MH

MindWalk Holdings Corp. Competitors Analysis of research-development-expenses

HYFT · NASDAQ
Companyresearch-development-expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
4.94M
-29.5%20.2%32.2% 
18.59M
25.3%-21.1%N/A
9.12M
-10.9%8.4%N/A
77.00M
-18.4%5.1%N/A
74.54M
25.1%23.0%N/A
60.22M
12.5%21.0%3.1%
CLNN logo
Clene Inc.
NASDAQ:CLNN
14.01M
-19.3%-13.2%N/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
18.80M
30.6%17.2%11.6%
3.92M
-57.9%-43.7%N/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
47.39M
13.0%10.9%1.1%
IMA logo
ImageneBio Inc
NASDAQ:IMA
28.52M
-21.8%-9.5%N/A
MH

MindWalk Holdings Corp. Fair Value Envelope

HYFT · NASDAQ

Our analysis suggests that HYFT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.82, this represents a potential HIDDEN relative to our calculated worth for MindWalk Holdings Corp..

Intrinsic Value
Current Price: $1.82